ROS1 Rearrangement: Molecular Oncology Tumor Boards

This free case-based activity includes a crowd-sourced discussion of a 40-year-old female with poorly differentiated adenocarcinoma consistent with a lung primary. Originally posted on a forum in the ASCO Connection, users now have the opportunity to claim CME, completion, or participation certificates for completing this activity.

Learning Objectives:

  • Analyze treatment options for patients with metastatic lung cancer
  • Evaluate the molecular testing options in patients with metastatic lung cancer
  • Describe the pathologist’s role in directing and interpreting molecular testing for advanced lung cancer

This activity was made available on 2/26/2015 and will be reviewed on an annual basis to determine continued availability. A maximum of 1 AMA PRA Category 1 Credit ™ is available.

Competencies Addressed

Medical Knowledge (ACGME, AAPA)
Health Promotion, Health Protection, Disease Prevention, and Treatment (ONS)